PLUME: A single-arm phase II trial evaluating the combination of pembrolizumab and lenvatinib in metastatic uveal melanoma (mUM) patients (pts) previously treated or not with tebentafusp.

Manuel Rodrigues, Sophie Piperno‐Neumann, Toulsie Ramtohul et al.|Journal of Clinical Oncology|2023

Cited by 2